You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 5,464,864


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,464,864
Title: Use of tetrahydrocarbazone derivatives as 5HT.sub.1 receptor agonists
Abstract:
Inventor(s): King; Francis D. (Harlow, GB2), Gaster; Laramie M. (Harlow, GB2), Kaumann; Alberto J. (Trumpington, GB2), Young; Rodney C. (Hertford, GB2)
Assignee: SmithKline Beecham P.L.C. (Brentford, GB2)
Application Number:08/167,846
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patent 5,464,864: A Detailed Analysis

Introduction

U.S. Patent 5,464,864, titled "Methods and compositions for the treatment of migraine," is a significant patent in the pharmaceutical industry, particularly in the treatment of migraines. This patent, held by Endo Pharmaceuticals, Inc., has been the subject of several legal disputes and is an example of how patent claims and scope can be critically analyzed.

Background of the Patent

The patent in question, U.S. Patent 5,464,864, was granted for methods and compositions related to the treatment of migraines using frovatriptan succinate. Frovatriptan is a selective serotonin receptor agonist, which is effective in treating acute migraine attacks.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically outline the novel and non-obvious aspects of the invention.

  • Claim 1: This claim generally describes the method of treating a migraine by administering a specific dosage of frovatriptan succinate.
  • Claim 5: This claim pertains to the composition of matter, specifically the formulation of frovatriptan succinate for oral administration.

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or limitations.

  • Claim 2: This claim specifies the dosage regimen, including the amount and frequency of administration.
  • Claim 6: This claim details the pharmaceutical formulation, including the excipients and other components.

Scope of the Patent

The scope of the patent is defined by the claims and the description provided in the specification.

Method of Treatment

The patent covers a method for treating migraines, which includes administering a specific dose of frovatriptan succinate. This method is designed to alleviate migraine symptoms effectively.

Composition of Matter

The patent also covers the composition of matter, which includes the formulation of frovatriptan succinate. This formulation is crucial for the effective delivery and absorption of the drug.

Patent Landscape

Prior Art and Anticipation

In patent disputes, prior art plays a crucial role in determining the validity of the patent claims. For example, in the case of Endo Pharmas. Inc. v. Mylan Pharmas. Inc., Mylan argued that U.S. Patent No. 4,257,952 anticipated the claims in the '864 patent. However, the court found that the disclosures in the '864 patent were sufficient to reasonably convey the subject matter of the claimed invention and that the inventors were in possession of it[5].

Patent Eligibility

Patent eligibility under 35 U.S.C. ยง 101 is another critical aspect of the patent landscape. While the '864 patent does not face issues related to abstract ideas or natural phenomena, it is essential to ensure that the claims are directed to patent-eligible subject matter. The focus here is on the specific application of frovatriptan succinate for treating migraines, which is a tangible and practical invention.

Legal Disputes and Enforcement

Litigation History

The '864 patent has been involved in several legal disputes, primarily related to patent infringement and validity. In Endo Pharmas. Inc. v. Mylan Pharmas. Inc., the court upheld the validity of the patent claims against Mylan's arguments of anticipation and lack of enablement[5].

Claim Construction

Claim construction is a critical aspect of patent litigation. The court's interpretation of the claims can significantly impact the outcome of a case. For instance, the court in Endo Pharmas. Inc. v. Mylan Pharmas. Inc. interpreted the term "treatment" to include the administration of the drug when migraine symptoms begin to manifest, distinguishing it from prophylaxis[5].

Statistical and Economic Impact

Allowance Rates

The allowance rate for pharmaceutical patents, such as the '864 patent, has seen significant changes over the years. According to a study by Carley, Hegde, and Marco, the allowance rate for pharmaceutical patents has decreased substantially, particularly for applications in the "Drugs and Medical Instruments" field[1].

Economic Impact

Patents like the '864 patent have a significant economic impact on the pharmaceutical industry. They protect the intellectual property of drug manufacturers, allowing them to recoup their investment in research and development. The exclusivity provided by the patent can also influence market dynamics and pricing strategies.

Expert Insights

Patent Prosecution

Experts in patent prosecution highlight the importance of carefully drafting and prosecuting patent applications to ensure broad yet defensible claims. For example, the use of continuation procedures, such as Requests for Continued Examination (RCEs), can be crucial in navigating the patent office's examination process[1].

Patent Scope

Alan C. Marco and Joshua D. Sarnoff, in their work on patent claims and scope, emphasize the importance of measuring patent scope to understand the breadth and impact of a patent. This includes analyzing claim-level statistics and document-level statistics to gauge the patent's influence on the industry[3].

Key Takeaways

  • Patent Claims: The '864 patent includes specific claims related to the method of treatment and composition of matter for frovatriptan succinate.
  • Scope: The scope of the patent is defined by these claims and the detailed description in the specification.
  • Legal Disputes: The patent has been involved in several legal disputes, including issues of anticipation and claim construction.
  • Economic Impact: The patent has significant economic implications for the pharmaceutical industry, protecting intellectual property and influencing market dynamics.
  • Allowance Rates: The allowance rate for pharmaceutical patents has decreased over time, reflecting stricter examination standards.

FAQs

What is the main subject matter of U.S. Patent 5,464,864?

The main subject matter of U.S. Patent 5,464,864 is the method and composition for treating migraines using frovatriptan succinate.

How has the allowance rate for pharmaceutical patents changed over time?

The allowance rate for pharmaceutical patents has decreased substantially over time, particularly for applications in the "Drugs and Medical Instruments" field[1].

What is the significance of claim construction in patent litigation?

Claim construction is critical in patent litigation as it determines the scope of the patent claims and can significantly impact the outcome of a case.

How do continuation procedures affect patent prosecution?

Continuation procedures, such as Requests for Continued Examination (RCEs), can be crucial in navigating the patent office's examination process and may affect the final outcome of the patent application[1].

What is the economic impact of patents like the '864 patent on the pharmaceutical industry?

Patents like the '864 patent protect intellectual property, allowing drug manufacturers to recoup their investment in research and development, and can influence market dynamics and pricing strategies.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,464,864

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,464,864

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9113802Jun 26, 1991
PCT Information
PCT FiledJune 17, 1992PCT Application Number:PCT/GB92/01082
PCT Publication Date:January 07, 1993PCT Publication Number: WO93/00086

International Family Members for US Patent 5,464,864

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0591280 ⤷  Subscribe SPC/GB03/014 United Kingdom ⤷  Subscribe
European Patent Office 0591280 ⤷  Subscribe C00591280/01 Switzerland ⤷  Subscribe
European Patent Office 0591280 ⤷  Subscribe C300103 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.